Biphasic flux profiles of melatonin: The Yin-Yang of transdermal permeation enhancement mediated by fatty alcohol enhancers

Journal of Pharmaceutical Sciences

Volumn 99, Issue 1, 2010, Pages 209-218

  Kandimalla, Karunya K ^a   Babu, R J ^b   Singh, M ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Fatty alcohols; Melatonin; Rat skin; Solubility parameters; Transdermal permeation; Vehicle

Indexed keywords

FATTY ALCOHOL; MELATONIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; HORMONE TRANSPORT; LIPOPHILICITY; MALE; MATHEMATICAL ANALYSIS; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SKIN PERMEABILITY;

EID: 73949092111     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21812     Document Type: Article

References (29)

1. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. 1991. Delayed sleep phase syndrome response to melatonin. Lancet 337:1121-1124.
2. Petrie K, Conaglen JV, Thompson L, Chamberlain K. 1989. Effects of melatonin on jet lag after long haul flight. Br Med J 298:705-707.
3. Waldhauser F, Vierhapper H, Oirich K. 1989. Abnormal circadian melatonin secretion in night shift workers. New Engl J Med 7:441-446.
4. Kanikkannan N, Andega S, Burton S, Babu RJ, Singh M. 2004. Formulation and in vitro evaluation of transdermal patches of melatonin. Drug Dev Ind Pharm 30:205-212.
5. Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, Gasco MR, Mauro A. 2007. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 7:3596-3601.
6. Fischer TW, Greif C, Fluhr JW, Wigger-Alberti W, Elsner P. 2004. Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution. Skin Pharmacol Physiol 17:190-194.
7. Kaushik D, Batheja P, Kilfoyle B, Rai V, Michniak-Kohn B. 2008. Percutaneous permeation modifiers: Enhancement versus retardation. Expert Opin Drug Deliv 5:517-529.
8. Vávrová K, Zbytovská J, Hrabálek A. 2005. Amphiphilic transdermal permeation enhancers: Structure-activity relationships. Curr Med Chem 12:2273-2291.
9. Lee BJ, Parrott KA, Ayres JW, Sack RL. 1994. Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res Commun Mol Pathol Pharmacol 85:337-346.
10. Kandimalla KK, Kanikkannan N, Singh M. 1999. Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. J Control Release 61:71-82.
11. Kikwai L, Kanikkannan N, Babu RJ, Singh M. 2002. Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J Control Release 83:307-311.
12. Kandimalla K, Kanikkannan N, Andega S, Singh M. 1999. Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo. J Pharm Pharmacol 51:783-790.
13. Kanikkannan N, Singh M. 2002. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 248:219-228.
14. Barton AFM. 1975. Solubility parameters. Chem Rev 75:731-753.
15. Sloan KB, Koch SAM, Siver KG, Flowers FP. 1986. Use of solubility parameters of drug and vehicle to predict flux through skin. J Invest Dermatol 87:244-252.
16. Sloan KB, Siver KG, Koch SA. 1986b. The effect of vehicle on the diffusion of salicylic acid through hairless mouse skin. J Pharm Sci 75:744-749.
17. Fedors RF. 1974. A method for estimating both the solubility parameters and molar volume of lipids. Polym Eng Sci 14:147-154.
18. Martin A, Wu PL, Velasquez T. 1985. Extended Hildebrand solubility approach: Sulfonamides in binary and ternary solvents. J Pharm Sci 74:277-282.
19. Chien YW, Xu H, Chiang C, Huang Y. 1988. Transdermal controlled administration of indomethacin. 1. Enhancement of skin permeability. Pharm Res 5:103-106.
20. Lee CK, Uchida T, Noguchi E, Kim N, Goto S. 1993. Skin permeation enhancement of tefagur by ethanol/panasate 800 or ethanol/water binary vehicle and combined effect of fatty acids and fatty alcohols. J Pharm Sci 82:1155-1159.
21. Wu P, Huang Y, Fang J, Tsai Y. 1997. In vitro percutaneous absorption of captopril. Int J Pharm 148:41-46.
22. Sherertz EF, Sloan KB, McTiernan RG. 1987. Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J Invest Dermatol 89:147-151.
23. Kai T, Mak VHW, Potts RO, Guy RH. 1990. Mechanism of percutaneous penetration enhancement: Effect of n-alkanols on the permeability barrier of hairless mouse skin. J Control Release 12:103-112.
24. Liu P, Kurihara-Bergstrom T, Good WR. 1991. Cotransport of estradiol and ethanol through human skin in vitro: Understanding the permeant/enhancer flux relationship. Pharm Res 8:938-944.
25. Levin J, Maibach H. 2005. The correlation between transepidermal water loss and percutaneous absorption: An overview. J Control Release 103:291-299.
26. Tsai J-C, Sheu H-M, Hung P-L, Cheng C-L. 2001. Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: Implications for the permeability of compromised skin. J Pharm Sci 90:1242-1254.
27. Nishihata T, Rytting JH, Kamada A, Matsumoto K, Takahashi K. 1990. Combined effect of alcohol and urea on the in vitro transport of indomethacin across rat dorsal skin. J Pharm Sci 79:487-489.
28. Andega S, Kanikkannan N, Singh M. 2001. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release 77:17-25.
29. Barry BW. 1987. Mode of action of penetration enhancers in human skin. J Control Release 6:85-97.